Global health officials mandate a new flu vaccine to combat a late-emerging, severe H3N2 variant, as current shots proved 37% ...
AstraZeneca (AZN) launches the first FDA-approved influenza vaccine available for self- or caregiver administration, providing a convenient, household-based option for seasonal flu vaccination ...
Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.
Zhejiang Difference Biological Technology Co. Ltd. (Diff Biotech)’s proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has received clinical trial approval from China’s National ...
No significant benefit seen for 2 doses when the age range was broadened to children younger than 9 years. HealthDay News — Receiving 2 doses of inactivated influenza vaccine (IIV) in the first year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results